MAR 10, 2016 11:12 AM PST

First US Uterus Transplant Failed, Organ Removed

WRITTEN BY: Xuan Pham

The Cleveland Clinic reported that the first uterus transplant in the U.S. has sadly failed. The organ was removed on Tuesday March 8, 2015, just shy of the two-week mark since it was first transplanted. It is not yet known what led to the "sudden complications" that prompted the removal of the transplanted womb.
 
Lindsey, the 26-year-old recipient, is reportedly “doing well and recovering.” In a statement, she said, “I just wanted to take a moment to express my gratitude towards all of my doctors. They acted very quickly to ensure my health and safety. Unfortunately I did lose the uterus to complications. However, I am doing okay and appreciate all of your prayers and good thoughts.”
 
Designed to give women who lack functioning uteri to have a chance at pregnancy, the procedure involves transplanting wombs from deceased donors into healthy female candidates. The donated organ then has to recover for 12 months before the woman attempt to conceive a baby via in vitro fertilization (IVF).
 
This lengthy process presents many possible avenues for complications, the biggest of which is organ rejection. Led by Dr. Andreas G. Tzakis, the team reported that Lindsey passed the first biopsy to check for rejection, indicating possibly other causes for the failure. These could include infections or issues with blood flow to the transplanted organ. The cause of the trouble won’t be confirmed until pathologists analyze the removed organ.
 
It is important to realize the transplant is still in its experimental phase, with trials far from perfect. Of nine uterus transplants that have taken place in Sweden, five have resulted in healthy babies. As risks and complications are inherent in any surgical procedure, it is worth noting that this unfortunate turn of events will be a valuable learning experience for everyone.  In addition to Cleveland Clinic, other U.S. medical centers are also planning uterus transplants trials. This includes Baylor University Medical Center at Dallas, Brigham and Women’s Hospital in Boston and the University of Nebraska Medical Center in Omaha.
 
Lindsey was part of Cleveland Clinic’s trial that’s planned for 10 eligible women. Despite the setback, Cleveland Clinic stated the trial “is still ongoing with a commitment to the advancement of medical research to provide an additional option for women and their families.”
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 06, 2020
Clinical & Molecular DX
Your Earwax Says You're Depressed
NOV 06, 2020
Your Earwax Says You're Depressed
Cortisol, commonly known as the “stress hormone”, is the body’s built-in alarm system that sends siren ...
NOV 16, 2020
Clinical & Molecular DX
How the CRISPR-based COVID Microlab Can Intercept the Pandemic
NOV 16, 2020
How the CRISPR-based COVID Microlab Can Intercept the Pandemic
The demand for diagnostic technologies to track COVID-19 infections and control community spread of the disease has only ...
FEB 11, 2021
Clinical & Molecular DX
Smartwatches Keep a Close Eye on Parkinson's Patients
FEB 11, 2021
Smartwatches Keep a Close Eye on Parkinson's Patients
Individuals with Parkinson’s disease experience a slow, progressive worsening of symptoms. What can begin as barel ...
FEB 11, 2021
Clinical & Molecular DX
Seeing if Hormone Therapy Will Work for Breast Cancer Patients
FEB 11, 2021
Seeing if Hormone Therapy Will Work for Breast Cancer Patients
Only around half of women diagnosed with breast cancer will benefit from hormonal therapy, a cancer treatment that adds, ...
FEB 16, 2021
Clinical & Molecular DX
What Dead Cells Can Tell Us About Our Health
FEB 16, 2021
What Dead Cells Can Tell Us About Our Health
Taking a sample of tissue called a biopsy from an organ suspected of harboring a pathology is a common diagnostic practi ...
FEB 25, 2021
Clinical & Molecular DX
Pure Gold: Mini Device Makes 3D Skin Maps
FEB 25, 2021
Pure Gold: Mini Device Makes 3D Skin Maps
Beauty is skin deep and so are wounds. Closely monitoring wound healing progress has been a challenge for doctors, mainl ...
Loading Comments...